Pharmaceutical Industry Information Portal

HomeNews

News

Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis

Samsung Biologics announced that it has reached an agreement with Biogen for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for...

U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib)

AbbVie announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults...

Expo 2020 in Dubai: Russian pharma industry adapts to pandemic, open to cooperation with Arab world

The 13th meeting of the Russian-Arab Business Council session was held on 25-26 January. Russia's pharmaceutical industry has managed not only to adapt to the...

Argentina displays interest in nasal form of Russia’s Sputnik V vaccine

Argentina has displayed an interest in the nasal form of Russia's Sputnik V coronavirus vaccine and other Russian developments for treating and preventing COVID-19,...

Gamaleya Institute ready to file documents to test new platforms for COVID vaccines

The Gamaleya Institute is ready to file papers to Russian Health Ministry to obtain permission for research of new platforms for COVID vaccines, Institute...

“Vector” assessed the risk of spreading a new type of coronavirus NeoCov

Experts from the Russian sanitary watchdog’s Vector center have been briefed about a new coronavirus discovered in South Africa, named NeoCov, the center said...
spot_img

Expert Articles

spot_img